Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Mar 18, 2024

30870_dirs_2024-03-18_42a2e56e-0034-4515-8483-d914312a35fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-03-14

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-14 Common Stock A 61490 Acquired 461221 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-14 Incentive Stock Option (Right to Buy) $63.75 A 1568 Acquired 2034-03-14 Common Stock (1568) Direct
2024-03-14 Non-Qualified Stock Option (Right to Buy) $63.75 A 69464 Acquired 2034-03-14 Common Stock (69464) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.

F4: Award comprised of Non Statutory Stock Options that will vest and become exercisable over 4 years in monthly installments starting April 15, 2024, with the final monthly installment vesting on March 14, 2028.